{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03860792",
            "orgStudyIdInfo": {
                "id": "STUDY00143457"
            },
            "organization": {
                "fullName": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Therapeutic Diets in Alzheimer's Disease",
            "officialTitle": "Therapeutic Diets in Alzheimer's Disease",
            "acronym": "TDAD",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "therapeutic-diets-in-alzheimer-s-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-10-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-02-28",
            "studyFirstSubmitQcDate": "2019-02-28",
            "studyFirstPostDateStruct": {
                "date": "2019-03-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Russell Swerdlow",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Kansas Medical Center"
            },
            "leadSponsor": {
                "name": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Aging (NIA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease."
        },
        "conditionsModule": {
            "conditions": [
                "Alzheimer Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "All outcomes assessors are masked from participant group assignment.",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ketogenic Diet",
                    "type": "EXPERIMENTAL",
                    "description": "Study partners will be instructed to assist participants in adherence to a 1:1 ketogenic diet (approximately 70% fat, \\<10% carbohydrate, and 20% protein as energy). The diet will encourage \u22654 servings of non-starchy vegetables and 1/2 cup of berries daily. Participants will be provided an emulsified medium chain triglyceride supplement with a target intake of 1-2 tablespoons per day and micronutrient supplements consisting of multivitamin, vitamin D, calcium, and phosphorus. After the 3-month ketogenic diet, participants will complete a 1-month washout period in which they halt adherence to the ketogenic diet and resume their normal diet.",
                    "interventionNames": [
                        "Behavioral: Ketogenic Diet"
                    ]
                },
                {
                    "label": "Therapeutic Lifestyles Changes Diet",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Study partners will be instructed to assist participants in adherence to the Therapeutic Lifestyles Changes diet. The diet consists of 20-35% fat, 50-60% carbohydrate, and \\~15% protein as energy. Fat intake will comprise \\<7% saturated fat, \u226420% monounsaturated fat, and \u226410% polyunsaturated fat as total energy. Cholesterol consumption will be \u2264200mg per day. Participants are encouraged to eat \u22652 servings of fruit and \u22655 servings of vegetables per day.",
                    "interventionNames": [
                        "Behavioral: Therapeutic Lifestyles Changes Diet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Ketogenic Diet",
                    "description": "Three-month 1:1 ketogenic diet intervention (approximately 70% fat, \\<10% carbohydrate, and 20% protein).",
                    "armGroupLabels": [
                        "Ketogenic Diet"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Therapeutic Lifestyles Changes Diet",
                    "description": "Three-month diet intervention that is low in fat and cholesterol, high in fruits, vegetables, and whole grains, and moderate in protein.",
                    "armGroupLabels": [
                        "Therapeutic Lifestyles Changes Diet"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in cognitive performance on the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADASCog11)",
                    "description": "Cognitive performance will be assessed by a psychometrician using the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADASCog11). The ADAS-Cog is an Alzheimer's disease specific, multi-domain cognitive assessment scored from 0-70 points with higher scores indicating poorer cognitive performance.",
                    "timeFrame": "Baseline, 12 Weeks"
                },
                {
                    "measure": "Change in cognitive performance on the Mini-Mental State Exam (MMSE)",
                    "description": "Global cognitive performance will be assessed by a psychometrician using the Mini-Mental State Exam (MMSE). The MMSE is a brief cognitive questionnaire with a maximum score of 30 points where higher scores indicate better cognitive performance.",
                    "timeFrame": "Baseline, 12 Weeks"
                },
                {
                    "measure": "Change in cognitive performance on the Logical Memory Test (LMT)",
                    "description": "The Logical Memory, subtest of the WMS-R is a standardized assessment of narrative episodic memory. A short story is orally presented, and the examinee is asked to recall the story immediately.",
                    "timeFrame": "Baseline, 12 Weeks"
                },
                {
                    "measure": "Change in cognitive performance by Stroop test",
                    "description": "Reaction time and accuracy will be assessed by a psychometrician using the Stroop test.",
                    "timeFrame": "Baseline, 12 Weeks"
                },
                {
                    "measure": "Change in Clinical Dementia Rating (CDR)",
                    "description": "The Clinical Dementia Rating is a 5-point scale (CDR 0, 0.5, 1, 2, and 3) used to characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias. CDR 0 indicates no dementia and higher values indicate more severe dementia. The scores of all six domains are averaged to form a global CDR score. Change in score from baseline to 3 months will be assessed.",
                    "timeFrame": "Baseline, 12 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in cerebral concentration of N-Acetylaspartate (NAA)",
                    "description": "Concentration of cerebral N-Acetylaspartate is measured using magnetic resonance spectroscopy in a 3T clinical scanner.",
                    "timeFrame": "Baseline, 12 Weeks"
                },
                {
                    "measure": "Change in blood platelet mitochondrial function",
                    "description": "Cytochrome c oxidase activity of blood platelets will be determined as a pseudo first order-rate constant (sec-1/mg protein) by measuring the oxidation of reduced cytochrome c at 550 nm.",
                    "timeFrame": "Baseline, 6 Weeks, 12 Weeks"
                },
                {
                    "measure": "Change in self-reported symptoms by study partner",
                    "description": "Severity of symptoms will be measured via a self-reported symptoms questionnaire, answered by participant study partners.",
                    "timeFrame": "Baseline, 6 Weeks, 12 Weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in blood ketone levels induced by ketogenic diet",
                    "description": "We will measure serum beta-hydroxybutyrate levels.",
                    "timeFrame": "Baseline, 6 Weeks, 12 Weeks"
                },
                {
                    "measure": "Proportion of days positive for urinary ketone production",
                    "description": "Participants will measure and report daily urinary ketone status using Ketostix (Bayer, Germany).",
                    "timeFrame": "Daily for 90 days (the length of the diet intervention)"
                },
                {
                    "measure": "Dietary intake characterization prior to and after ketogenic diet initiation",
                    "description": "Changes in food and nutrient intake will be assessed by monthly 3-day food records completed by participant study partners.",
                    "timeFrame": "Baseline, 6 Weeks, 12 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of AD by current McKhann et al. criteria\n* CDR global score of 0.5 or 1\n* Agreed cooperation from an appropriate study partner\n* Speaks English as primary language\n* Age 50 to 90\n* No medication changes within the past 30 days\n\nExclusion Criteria:\n\n* Resides in a nursing home or dementia special care unit, or cannot control diet\n* A potentially confounding serious medical risk including insulin-requiring diabetes, cancer requiring chemotherapy or radiation within the past 5 years, or a recent cardiac event (i.e. heart attack, angioplasty, etc.)\n* Participating in another clinical trial or using an investigational drug or therapy within 30 days of the Screening Visit\n* A history of renal stones",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessica Keller, MS",
                    "role": "CONTACT",
                    "phone": "913-588-5355",
                    "email": "kkali17@kumc.edu"
                },
                {
                    "name": "Matthew Taylor, PHD",
                    "role": "CONTACT",
                    "phone": "913-588-5363",
                    "email": "mtaylor3@kumc.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Clinical and Translational Science Unit",
                    "status": "RECRUITING",
                    "city": "Fairway",
                    "state": "Kansas",
                    "zip": "66205",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.02223,
                        "lon": -94.6319
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000544",
                    "term": "Alzheimer Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "relevance": "LOW"
                },
                {
                    "id": "M21009",
                    "name": "Micronutrients",
                    "relevance": "LOW"
                },
                {
                    "id": "M16885",
                    "name": "Trace Elements",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M17550",
                    "name": "Vitamin D",
                    "relevance": "LOW"
                },
                {
                    "id": "M6003",
                    "name": "Cholecalciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "T440",
                    "name": "Calciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "T442",
                    "name": "Cholecalciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "T479",
                    "name": "Vitamin D3",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}